表紙
市場調査レポート

重症肢虚血:世界の治験レビュー

Critical Limb Ischemia Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 244196
出版日 ページ情報 英文 81 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
重症肢虚血:世界の治験レビュー Critical Limb Ischemia Global Clinical Trials Review, H2, 2014
出版日: 2014年11月28日 ページ情報: 英文 81 Pages
概要

重症肢虚血は、動脈が詰まって手足に流れる血流が減少するのが特徴です。症状としては、虚血性潰瘍(ただれ)、安静時疼痛などがあります。 治療は禁煙、薬物療法、手術などがあります。調査によると、米国での発生率は、年100万人に約300人の割合だそうです。

当レポートでは、重症肢虚血に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

イントロダクション

  • 重症肢虚血
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 上位5ヶ国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 主要国における治験件数; 中東/アフリカ地域
    • 主要国における治験件数; 中南米

G7諸国における治験件数: 重症肢虚血治験件数の心臓血管治験件数に対する比率

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数: 重症肢虚血治験件数の心臓血管治験件数に対する比率

フェーズ(相)別治験件数: E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

治験主要参加企業 - 重症肢虚血治療薬

有望な薬剤

治験のプロファイル

  • 代表的な企業の治験の概要
    • AnGes MG, Inc.
    • ViroMed Co., Ltd.
    • United Therapeutics Corporation
    • Sanofi
    • Pluristem Therapeutics Inc.
    • TheraVitae Inc.
    • ReNeuron Group plc
    • Intrexon Corporation
    • C. H. Boehringer Sohn AG & Co. KG
    • Aastrom Biosciences, Inc.
  • 代表的な研究機関/病院の治験の概要
    • Fundacion Progreso y Salud
    • Leiden University Medical Center
    • Tufts University
    • Northwestern University
    • 関西ろうさい病院
    • Institute of Biomedical Research and Innovation Hospital
    • Sun Yat-sen University
    • CHU de Reims
    • University of Bern
    • 九州大学

5大治験プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2430CTIDB

GlobalData's clinical trial report, "Critical Limb Ischemia Global Clinical Trials Review, H2, 2014" provides data on the Critical Limb Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Critical Limb Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Critical Limb Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Critical Limb Ischemia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Critical Limb Ischemia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Critical Limb Ischemia Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Critical Limb Ischemia
    • Nov 18, 2014: Juventas Therapeutics Presents Phase II Data at AHA Scientific Sessions That Shows JVS-100 is Safe, Potentially Effective in Patients with Critical Limb Ischemia
    • Oct 05, 2014: AnGes Starts Global Phase III Clinical Trials of Collategene for Critical Limb Ischemia
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AnGes MG, Inc.
      • Clinical Trial Overview of AnGes MG, Inc.
      • ViroMed Co., Ltd.
      • Clinical Trial Overview of ViroMed Co., Ltd.
      • United Therapeutics Corporation
      • Clinical Trial Overview of United Therapeutics Corporation
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Pluristem Therapeutics Inc.
      • Clinical Trial Overview of Pluristem Therapeutics Inc.
      • TheraVitae Inc.
      • Clinical Trial Overview of TheraVitae Inc.
      • ReNeuron Group plc
      • Clinical Trial Overview of ReNeuron Group plc
      • Intrexon Corporation
      • Clinical Trial Overview of Intrexon Corporation
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Aastrom Biosciences, Inc.
      • Clinical Trial Overview of Aastrom Biosciences, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Fundacion Progreso y Salud
      • Clinical Trial Overview of Fundacion Progreso y Salud
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
      • Tufts University
      • Clinical Trial Overview of Tufts University
      • Northwestern University
      • Clinical Trial Overview of Northwestern University
      • Kansai Rosai Hospital
      • Clinical Trial Overview of Kansai Rosai Hospital
      • Institute of Biomedical Research and Innovation Hospital
      • Clinical Trial Overview of Institute of Biomedical Research and Innovation Hospital
      • Sun Yat-sen University
      • Clinical Trial Overview of Sun Yat-sen University
      • CHU de Reims
      • Clinical Trial Overview of CHU de Reims
      • University of Bern
      • Clinical Trial Overview of University of Bern
      • Kyushu University
      • Clinical Trial Overview of Kyushu University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Critical Limb Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Critical Limb Ischemia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Critical Limb Ischemia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ViroMed Co., Ltd., 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by TheraVitae Inc., 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ReNeuron Group plc, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Intrexon Corporation, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aastrom Biosciences, Inc., 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion Progreso y Salud, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts University, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansai Rosai Hospital, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Biomedical Research and Innovation Hospital, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by CHU de Reims, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bern, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2014*

List of Figures

  • Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Critical Limb Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Critical Limb Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top